CD274 and infection: We found a strong induction of PD-L1 expression rising from a baseline of 14% (mock infection) to 44% (MeV infection) (Fig. 3) thus making human sarcoma cells prone for a combination therapy of MeV and immune-checkpoint inhibitors.